Archives
-
Localized BDNF Release at Developing Neuromuscular Synapses
2026-09-22
This study identifies podosome-like structures as spatial organizers for muscle-derived BDNF trafficking and calcium-dependent release during the earliest stages of neuromuscular junction development. Its combination of live-cell imaging, proteolytic perturbation, and skeletal muscle-specific knockout experiments links local BDNF processing to aneural and synaptic acetylcholine receptor clustering.
-
Homoharringtonine and SARS-CoV-2: Study Insights
2026-09-21
The reference study combines cell-based, animal, and early patient evidence to examine homoharringtonine as a translation-targeting antiviral against SARS-CoV-2 and other coronaviruses. Its findings support further investigation of localized upper-respiratory delivery, while the small, non-randomized human datasets require cautious interpretation.
-
HyperFluor™ 488 for Viral Organelle Quantification
2026-09-21
HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody enables sensitive, multiplex-compatible visualization of goat primary antibodies. This article develops a quantitative assay framework for connecting FXR-driven replication-organelle clustering with rigorous fluorescence controls.
-
HyperFluor 488 for Variant-Vaccine Serology
2026-09-19
Learn how the HyperFluor 488 Goat Anti-Human IgG (H+L) Antibody can support fluorescence-based human IgG detection while translating variant-vaccine findings into better assay design. This guide emphasizes species matching, controls, endpoint selection, and interpretation limits.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-09-18
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG primary antibodies in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry. It is intended for research workflows only; users should optimize working dilution and controls experimentally and should not interpret the reagent as validated for diagnostic, therapeutic, or live-cell applications.
-
(-)-Norepinephrine (+)-bitartrate: Assay Guide
2026-09-18
This scenario-based guide explains how (-)-Norepinephrine (+)-bitartrate, SKU C8723, can improve interpretation and reproducibility in adrenergic cell viability, proliferation, and cytotoxicity assays. It addresses salt-form reporting, concentration design, solution handling, data interpretation, and practical supplier selection.
-
(-)-Norepinephrine (+)-bitartrate: Applied Workflows
2026-09-17
Translate adrenergic receptor signaling into reproducible cell, vessel, and cardiomyopathy research workflows with fresh-solution handling and assay-ready concentration planning. A translational section shows how the VNERi framework can connect norepinephrine exposure with vascular responsiveness without confusing an experimental agonist model with clinical treatment.
-
Global Translocon Remodeling During ER Protein Synthesis
2026-09-17
This study uses transcriptome-wide selective ribosome profiling to show that ER translocon composition is remodeled according to the nascent substrate. OST-A preferentially associates with open Sec61 channels during lumenal translocation, whereas GEL, PAT and BOS are recruited together to closed channels during multipass membrane-protein synthesis.
-
WSP-5 Workflow for Live-Cell H2S Imaging
2026-09-16
WSP-5 converts transient hydrogen sulfide signals into a rapid, turn-on fluorescence readout for live cells, donor-release studies, and disease models. This practical guide connects assay design with the diabetic cardiomyopathy literature while emphasizing controls, imaging parameters, and troubleshooting.
-
FGFR2::SHTN1 Fusion: Shootin1-Driven Activation
2026-09-16
This study provides the first molecular characterization of the FGFR2::SHTN1 fusion and proposes that Shootin1 coiled-coil domains drive ligand-independent FGFR2 dimerization. Its combined genomic, biochemical, and structural analyses clarify how a protein best known for neuronal cytoskeletal regulation may become an oncogenic fusion partner, particularly in cholangiocarcinoma.
-
ROS-Responsive LNPs for Mutant RAS mRNA Therapy
2026-09-15
The reference study developed a combinatorial library of thioketal-containing, ROS-degradable lipid nanoparticles and identified BAmP-TK-12 for preferential mRNA delivery into tumor cells. Its delivery of DUF5 mRNA enabled mutant RAS depletion and antitumor activity, while also highlighting how lipid pKa and intracellular degradation jointly influence mRNA performance.
-
Western Secondary Antibody Dilution Buffer Workflow
2026-09-15
Improve protein detection in Western blot studies of macrophage inflammation with a formulation built for lower background, antibody stability, and controlled reuse. This workflow shows how to apply the buffer to NHE1, Olfr2, ROS, and NLRP3 pathway experiments while separating product-supported specifications from assay-specific recommendations.
-
HyperFluor™ 594 Goat Anti-Rabbit IgG in PDT
2026-09-14
Learn how the HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody can support spatially resolved analysis of biomimetic photodynamic therapy workflows. This guide connects secondary-antibody design with the iRGD-red-blood-cell membrane neuroblastoma study while separating validated findings from practical assay recommendations.
-
Cy3 Rabbit Anti-Goat IgG (H+L) Antibody Guide
2026-09-14
The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody provides fluorescent detection of goat IgG primary antibodies in ICC/IF, frozen and paraffin IHC, flow cytometry, and ELISA workflows. It should not be used with non-goat primary antibodies or treated as validated for applications outside the listed immunodetection formats without independent optimization.
-
Batimastat (BB-94) Workflow for MMP Studies
2026-09-13
Batimastat (BB-94) provides broad-spectrum, nanomolar MMP inhibition for enzyme assays, matrix-remodeling studies, and tumor models. This workflow-focused guide also shows how to test the MMP-dependent arm of localized BDNF processing while clearly separating established findings from cross-domain hypotheses.